Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Expedia Group
EXPE
$38.6B
| $207M | 0.4% |
1,760,103
-148,169
| -8% | -$17.1M |
|
27
Exelon
EXC
$45.1B
| $199M | 0.39% |
9,387,495
-1,208,473
| -11% | -$27.2M |
|
28
Microsoft
MSFT
$3.59T
| $199M | 0.38% |
4,487,842
+2,730,279
| +155% | +$123M |
|
|
VIAB
29
DELISTED
Viacom Inc. Class B
VIAB
| $195M | 0.38% |
4,510,984
+4,295,294
| +1,991% | +$213M |
|
30
Visa
V
$693B
| $192M | 0.37% |
2,753,636
+746,720
| +37% | +$53.3M |
|
31
Biogen
BIIB
$32B
| $182M | 0.35% |
624,834
-295,256
| -32% | -$97.5M |
|
32
Cisco
CSCO
$438B
| $182M | 0.35% |
6,936,357
+3,259,317
| +89% | +$88M |
|
33
Xcel Energy
XEL
$47.7B
| $177M | 0.34% |
4,985,008
-226,152
| -4% | -$7.69M |
|
|
YHOO
34
DELISTED
Yahoo Inc
YHOO
| $173M | 0.34% |
5,997,656
+2,510,526
| +72% | +$87.1M |
|
35
CVS Health
CVS
$119B
| $173M | 0.34% |
1,795,005
+501,690
| +39% | +$52.7M |
|
|
TWX
36
DELISTED
Time Warner Inc
TWX
| $171M | 0.33% |
2,492,253
-330,457
| -12% | -$26M |
|
37
Hartford Financial Services
HIG
$36.9B
| $170M | 0.33% |
3,718,817
-603,448
| -14% | -$27.9M |
|
38
Kimberly-Clark
KMB
$36.4B
| $168M | 0.33% |
1,541,523
+520,684
| +51% | +$57.4M |
|
39
Edwards Lifesciences
EW
$51.8B
| $168M | 0.32% |
7,074,660
-385,608
| -5% | -$9.31M |
|
|
EGN
40
DELISTED
Energen
EGN
| $165M | 0.32% |
3,307,757
-121,288
| -4% | -$6.54M |
|
41
SBA Communications
SBAC
$19.4B
| $165M | 0.32% |
1,573,105
+467,894
| +42% | +$54.5M |
|
42
Vertex Pharmaceuticals
VRTX
$139B
| $164M | 0.32% |
1,579,374
+1,167,738
| +284% | +$150M |
|
43
Conagra Brands
CAG
$7.89B
| $162M | 0.31% |
5,126,391
+4,446,180
| +654% | +$149M |
|
44
Boston Scientific
BSX
$73B
| $161M | 0.31% |
9,800,911
+5,419,293
| +124% | +$92.6M |
|
45
TechnipFMC
FTI
$30.4B
| $157M | 0.3% |
6,823,207
-393,644
| -5% | -$9.9M |
|
46
Lowe's Companies
LOW
$121B
| $157M | 0.3% |
2,282,311
+1,136,276
| +99% | +$78.1M |
|
|
XEC
47
DELISTED
CIMAREX ENERGY CO
XEC
| $156M | 0.3% |
1,524,411
+920,649
| +152% | +$98.1M |
|
48
T-Mobile US
TMUS
$196B
| $155M | 0.3% |
3,880,941
+241,684
| +7% | +$9.64M |
|
49
Ovintiv
OVV
$18.5B
| $150M | 0.29% |
4,652,329
+1,764,238
| +61% | +$67.6M |
|
|
50
Sempra
SRE
$54.2B
| $148M | 0.29% |
3,069,116
-3,895,340
| -56% | -$192M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.